IGHV2OR16-5: A Drug Target / Disease Biomarker (G100129631)

Target Name: IGHV2OR16-5

NCBI ID: G100129631

IGHV2OR16-5

Other Name(s): immunoglobulin heavy variable 2/OR16-5 (non-functional) | IGHV2OR165 | Immunoglobulin heavy variable 2/OR16-5 (non-functional)

IGHV2OR16-5: A Drug Target / Disease Biomarker

IGHV2OR16-5 is a protein that is expressed in most tissues of the body. It is a key regulator of the immune response and has been identified as a potential drug target in the treatment of various diseases.

The IGHV2OR16-5 protein is a member of the interleukin family, which is a group of cytokines and other immune molecules that play a critical role in the immune response. The IGHV2OR16-5 protein is expressed in most tissues of the body, including the skin, hair, and nails, and has been shown to play a role in the regulation of inflammation, immune cell function, and tissue repair.

One of the key functions of the IGHV2OR16-5 protein is its role in the regulation of T cell development and function. T cells are a critical part of the immune system, responsible for cell-mediated immunity against viruses, bacteria, and other pathogens. The IGHV2OR16-5 protein is involved in the regulation of T cell development and function by promoting the expression of genes that are involved in T cell proliferation, differentiation, and survival.

In addition to its role in T cell development, the IGHV2OR16-5 protein is also involved in the regulation of inflammation. Chronic inflammation can lead to a host of diseases, including heart disease, diabetes, and cancer. The IGHV2OR16-5 protein has been shown to play a role in the regulation of inflammation by promoting the production of pro-inflammatory cytokines and limiting the production of anti-inflammatory cytokines.

The IGHV2OR16-5 protein has also been identified as a potential drug target in the treatment of various diseases. For example, studies have shown that inhibiting the activity of the IGHV2OR16-5 protein has the potential to treat autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. In addition, the IGHV2OR16-5 protein has also been shown to be involved in the regulation of cancer progression, and inhibiting its activity has the potential to treat cancer.

Overall, the IGHV2OR16-5 protein is a promising drug target for the treatment of various diseases. Further research is needed to fully understand its functions and potential therapeutic uses.

Protein Name: Immunoglobulin Heavy Variable 2/OR16-5 (non-functional)

The "IGHV2OR16-5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHV2OR16-5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets